Erratum: Role of oxidative stress in hearing impairment in patients with type two diabetes mellitus (Journal of Laryngology and Otology (2009) 123 (957-963) DOI: 10.1017/S0022215109004502);Role of oxidative stress in hearing impairment in patients with type two diabetes mellitus

Journal of Laryngology and Otology

Volumn 123, Issue 9, 2009, Pages 957-963

  Aladag, I ^a   Eyibilen, A ^a   Guven M ^a   Erkokmaz, U ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

Diabetes Mellitus; Oxidative Stress; Sensorineural Hearing Loss

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; NITRIC OXIDE;

ADULT; ARTICLE; AUDIOMETRY; BODY WEIGHT; CONTROLLED STUDY; FEMALE; HEARING; HEARING IMPAIRMENT; HUMAN; HYPOTHESIS; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; OXIDATIVE STRESS; PERCEPTION DEAFNESS; PERIPHERAL NEUROPATHY; TYMPANOMETRY;

EID: 70450183683     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215112003052     Document Type: Erratum

References (60)

1. Ravecca F, Berrettini S, Bruschini L, Segnini G, Sellari-Franceschini S. Progressive sensorineural hearing loss: metabolic, hormonal and vascular etiology [in Italian]. Acta Otorhinolaryngol Ital 1998;18:42-50
2. de España R, Biurrun O, Lorente J, Traserra J. Hearing and diabetes. ORL J Otorhinolaryngol Relat Spec 1995; 57:325-327
3. Taylor IG, Irwin J. Some audiological aspects of diabetes mellitus. J Laryngol Otol 1978;92:99-113
4. Cullen JR, Cinnamond MJ. Hearing loss in diabetics. J Laryngol Otol 1993;107:179-182
5. Parving A, Elberling C, Balle V, Parbo J, Dejgaard A, Parving HH. Hearing disorders in patients with insulindependent diabetes mellitus. Audiology 1990;29:113-121
6. Park MS, Park SW, Choi JH. Distortion product otoacoustic emissions in diabetics with normal hearing. Scand Audiol Suppl 2001;52:148-151
7. Di Leo MA, Di Nardo W, Cercone S, Ciervo A, Lo Monaco M, Greco AV et al. Cochlear dysfunction in IDDM patients with subclinical peripheral neuropathy. Diabetes Care 1997;20:824-828
8. Lisowska G, Namys?owski G, Morawski K, Strojek K. Cochlear dysfunction and diabetic microangiopathy. Scand Audiol Suppl 2001;52:199-203
9. Sasso FC, Salvatore T, Tranchino G, Cozzolino D, Caruso AA, Persico M et al. Cochlear dysfunction in type 2 diabetes: a complication independent of neuropathy and acute hyperglycemia. Metabolism 1999;48:1346-1350
10. Hunt JV, Smith CC, Wolff SP. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 1990;39:1420-1424
11. Ramakrishna V, Jailkhani R. Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol 2008;45:41-46
12. Bhatia S, Shukla R, Venkata Madhu S, Kaur Gambhir J, Madhava Prabhu K. Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 2003;36:557-562
13. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999;48:1-9
14. Ha H, Kim KH. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int Suppl 1995;51: 18-21
15. Lehmann R, Schleicher ED. Molecular mechanism of diabetic nephropathy. Clin Chim Acta 2000;297:135-144
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275
17. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500
18. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-169
19. Esterbaur H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407-421
20. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stantman ER. Determination of carbonyl content in oxidatively modified proteins. In: Packer L Glazer A (Eds). Methods in Enzymology V 186, Oxygen Radicals in Biological Systems. New York, Academic Press 1990. pp. 464-478.
21. Cortas NK,WakidNW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990;36:1440-1443
22. Chisolm TH, Willott JF, Lister JJ. The aging auditory system: anatomic and physiologic changes and implications for rehabilitation. Int J Audiol 2003;42:3-10
23. Evans P, Halliwell B. Free radicals and hearing. Cause, consequence, and criteria. Ann N Y Acad Sci 1999;884: 19-40
24. Takumida M, Anniko M, Popa R, Zhang DM. Pharmacological models for inner ear therapy with emphasis on nitric oxide. Acta Otolaryngol 2001;121:16-20
25. Yamane H, Nakai Y, Takayama M, Konishi K, Iguchi H, Nakagawa T et al. The emergence of free radicals after acoustic trauma and strial blood flow. Acta Otolaryngol Suppl 1995;519:87-92
26. Ohlemiller KK, Wright JS, Dugan LL. Early elevation of cochlear reactive oxygen species following noise exposure. Audiol Neurootol 1999;4:229-236
27. Hu BH, Henderson D, Nicotera TM. Involvement of apoptosis in progression of cochlear lesion following exposure to intense noise. Hear Res 2002;166:62-71
28. Gallou G, Ruelland A, Legras B, Maugendre D, Allannic H, Cloarec L. Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin Chim Acta 1993;214:227-234
29. Altomare E, Vendemiale G, Chicco D, Procacci V, Cirelli F. Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Diabetes Metab 1992;18:264-271
30. Heistad DD. Oxidative stress and vascular disease: 2005 Duff lecture. Arterioscler Thromb Vasc Biol 2006;26:689-695
31. Mooradian AD. Increased serum conjugated dienes in elderly diabetic patients. J Am Geriatr Soc 1991;39:571-574
32. Kaji H, Kurasaki M, Ito K, Saito T, Saito K, Niioka T et al. Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type 2 (non-insulin-dependent) diabetic women [in English]. Klin Wochenschr 1985;63: 765-768
33. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P et al. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 1995;98:469-475
34. Velázquez E, Winocour PH, Kesteven P, Alberti KG, Laker MF. Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabet Med 1991;8:752-758
35. Miles AM, Bohle DS, Glassbrenner PA, Hansert B, Wink DA, Grisham MB. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 1996;271:40-47
36. Lüscher TF, Noll G. Endothelium dysfunction in the coronary circulation. J Cardiovasc Pharmacol 1994;24:16-26
37. Evans P, Halliwell B. Free radicals and hearing. Cause, consequence, and criteria. Ann N Y Acad Sci 1999;884: 19-40
38. Seidman MD, Shivapuja BG, Quirk WS. The protective effects of allopurinol and superoxide dismutase on noiseinduced cochlear damage. Otolaryngol Head Neck Surg 1993;109:1052-1056
39. Elliott TG, Cockcroft JR, Groop PH, Viberti GC, Ritter JM. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci (Lond) 1993;85:687-693
40. Brechtelsbauer PB, Nuttall AL, Miller JM. Basal nitric oxide production in regulation of cochlear blood flow. Hear Res 1994;77:38-42
41. Ren T, Nuttall AL, Miller JM. ATP-induced cochlear blood flow changes involve the nitric oxide pathway. Hear Res 1997;112:87-94
42. Cohen RA. Role of nitric oxide in diabetic complications. Am J Ther 2005;12:499-502
43. Durante W, Sen AK, Sunahara FA. Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats. Br J Pharmacol 1988;94:463-468
44. Mayhan WG. Impairment of endothelium-dependent dilatation of the basilar artery during diabetes mellitus. Brain Res 1992;580:297-302
45. Vanizor B, Orem A, Karahan SC, Kiran E, Erem C, Aliyaziciog ?lu Ret al. Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications. Diabetes Res Clin Pract 2001;54:33-39
46. Aydin A, Orhan H, Sayal A, Ozata M, Sahin G, Işimer A. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control. Clin Biochem 2001;34:65-70
47. Chiarelli F, Cipollone F, Romano F, Tumini S, Costantini F, di Ricco L et al. Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes 200l;49:1258-1263
48. Sharma A, Kharb S, Chugh SN, Kakkar R, Singh GP. Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism 2000;49:160-162
49. Matkovics B, Varga SI, Szabó L,Witas H. The effect of diabetes on the activities of the peroxide metabolism enzymes. Horm Metab Res 1982;14:77-79
50. Rema M, Mohan V, Bhaskar A, Shanmugasundaram KR. Does oxidant stress play a role in diabetic retinopathy? Indian J Ophthalmol 1995;43:17-21
51. Matkovics B, Kotormán M, Varga IS, Hai DQ, Salgó L, Novák Z. Pro-antioxidant and rheologic studies in the blood of type 2 diabetic patients [in English]. Acta Physiol Hung 1997-1998;85:107-112 (Pubitemid 128500294)
52. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 1996;90: 255-260
53. Mart́n-Gallán P, Carrascosa A, Gussinye M, Doḿnguez C. Estimation of lipoperoxidative damage and antioxidant status in diabetic children: relationship with individual antioxidants. Free Radic Res 2005;39:933-942
54. Peuchant E, Brun JL, Rigalleau V, Dubourg L, Thomas MJ, Daniel JY et al. Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes. Clin Biochem 2004;37:293-298
55. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003;52:2346-2352
56. Nakamura M, Ozaki M, Fuchinoue S, Teraoka S, Ota K. Ascorbic acid prevents ischemia-reperfusion injury in the rat small intestine. Transpl Int 1997;10:89-95
57. Byrka-Owczarek K, Steplewska-Mazur K, Krasoń M, Bohosiewicz J, Koszutski T, Wojtynek G. The evaluation of the protective action of antioxidants on small intestine of rabbits experimentally injured by ischemia and reperfusion. J Pediatr Surg 2004;39:1226-1229
58. Shimizu MH, Araujo M, Borges SM, de Tolosa EM, Seguro AC. Influence of age and vitamin E on postischemic acute renal failure. Exp Gerontol 2004;39:825-830
59. Bursell SE, ClermontAC,Aiello LP,Aiello LM, Schlossman DK, Feener EP et al. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 1999;22:1245-1251
60. Le T, Keithley EM. Effects of antioxidants on the aging inner ear. Hear Res 2007;226:194-202